108 related articles for article (PubMed ID: 8735793)
1. Family issues in continuous infusion therapy with factor VIII.
Manco-Johnson MJ
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
[TBL] [Abstract][Full Text] [Related]
2. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Goldsmith JC
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Morfini M; Messori A; Longo G
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and continuous infusion for hemophilia: can we afford it?
Aledort LM; Bohn RL
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S35-7. PubMed ID: 8735795
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis in haemophilic children.
Liesner RJ
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
[TBL] [Abstract][Full Text] [Related]
7. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.
DiMichele DM; Lasak ME; Miller CH
Am J Hematol; 1996 Feb; 51(2):99-103. PubMed ID: 8579073
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
[TBL] [Abstract][Full Text] [Related]
9. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
10. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
11. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
12. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic infusion regimens in the management of hemophilia.
Ljung RC
Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
[TBL] [Abstract][Full Text] [Related]
14. Advances in care of children with hemophilia.
Manco-Johnson MJ; Riske B; Kasper CK
Semin Thromb Hemost; 2003 Dec; 29(6):585-94. PubMed ID: 14719175
[TBL] [Abstract][Full Text] [Related]
15. Vascular access in hemophilia.
Powell TW; Blumoff RL; Mandel SR
Am Surg; 1981 Sep; 47(9):408-9. PubMed ID: 6792959
[TBL] [Abstract][Full Text] [Related]
16. Design and assessment of clinical trials on continuous infusion.
Schulman S; Martinowitz U
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S7-9. PubMed ID: 8735790
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
[TBL] [Abstract][Full Text] [Related]
19. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
Brühl P; Weibbach L; Brackmann HH
MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]